v3.26.3
Supplemental Financial Information - Schedule of Supplemental Statement of Cash Flows (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities          
Net income $ (76.8) $ 112.5 $ 6.1 $ 599.2  
Adjustments to reconcile net income to net cash flows from operating activities:          
Depreciation and amortization     153.8 143.1  
Equity-based compensation 100.8 90.7 336.6 287.1  
Non-cash performance allocations and incentive fees     686.7 13.1  
Non-cash principal investment (income) loss     (241.2) (50.2)  
Other non-cash amounts     (2.5) 35.9  
Purchases of investments     (340.2) (251.1)  
Proceeds from the sale of investments     561.4 664.0  
Payments of contingent consideration     (14.8) (2.7)  
Change in deferred taxes, net     (109.0) (67.5)  
Change in due from affiliates and other receivables     0.9 (8.7)  
Change in deposits and other     19.8 (25.4)  
Change in accounts payable, accrued expenses and other liabilities     (116.9) 37.8  
Change in accrued compensation and benefits     (187.4) (61.4)  
Change in due to affiliates     20.6 25.1  
Change in lease right-of-use assets and lease liabilities     (11.7) (9.7)  
Change in deferred revenue     229.8 226.7  
Net cash used in operating activities     (881.8) (2,080.4)  
Cash flows from investing activities          
Purchases of fixed assets, net     (87.5) (57.4)  
Net cash used in investing activities     (87.5) (57.4)  
Cash flows from financing activities          
Issuance of 5.05% senior notes due 2035, net of financing costs     0.0 792.9  
Payments on CLO borrowings     (67.9) (52.0)  
Proceeds from CLO borrowings, net of financing costs     97.9 64.8  
Dividends to common shareholders     (376.6) (379.2)  
Contributions from non-controlling interest holders     867.6 599.1  
Distributions to non-controlling interest holders     (323.0) (308.1)  
Common shares repurchased and net share settlement of equity-based awards     (719.3) (482.8)  
Change in due to/from affiliates financing activities     (212.1) 25.6  
Net cash provided by financing activities     603.5 3,015.4  
Effect of foreign exchange rate changes     (23.5) 82.3  
Increase (decrease) in cash, cash equivalents and restricted cash     (389.3) 959.9  
Cash, cash equivalents and restricted cash, beginning of period     1,973.6 1,266.5  
Cash, cash equivalents and restricted cash, end of period 1,584.3 2,226.4 1,584.3 2,226.4  
Reconciliation of cash, cash equivalents and restricted cash, end of period:          
Cash and cash equivalents 1,583.5 2,221.7 1,583.5 2,221.7 $ 1,970.2
Restricted cash 0.8 4.7 0.8 4.7 3.4
Total cash, cash equivalents and restricted cash, end of period 1,584.3 2,226.4 1,584.3 2,226.4 1,973.6
Cash and cash equivalents held at Consolidated Funds $ 1,021.5 1,037.3 $ 1,021.5 1,037.3 1,235.1
5.050% Senior Notes Due 9/19/2035          
Reconciliation of cash, cash equivalents and restricted cash, end of period:          
Interest rate (percent) 5.05%   5.05%    
Consolidated Operating Entities          
Cash flows from operating activities          
Net income     $ (25.2) 486.0  
Adjustments to reconcile net income to net cash flows from operating activities:          
Depreciation and amortization     153.8 143.1  
Equity-based compensation     336.6 287.1  
Non-cash performance allocations and incentive fees     680.0 2.7  
Non-cash principal investment (income) loss     (92.8) (32.5)  
Other non-cash amounts     (2.5) 35.9  
Purchases of investments     (995.2) (872.6)  
Proceeds from the sale of investments     977.2 807.6  
Payments of contingent consideration     (14.8) (2.7)  
Change in deferred taxes, net     (109.0) (67.5)  
Change in due from affiliates and other receivables     1.0 (8.1)  
Change in deposits and other     19.8 (25.4)  
Change in accounts payable, accrued expenses and other liabilities     (116.9) 37.8  
Change in accrued compensation and benefits     (187.4) (61.4)  
Change in due to affiliates     20.6 25.1  
Change in lease right-of-use assets and lease liabilities     (11.7) (9.7)  
Change in deferred revenue     229.8 226.7  
Net cash used in operating activities     863.3 972.1  
Cash flows from investing activities          
Purchases of fixed assets, net     (87.5) (57.4)  
Net cash used in investing activities     (87.5) (57.4)  
Cash flows from financing activities          
Issuance of 5.05% senior notes due 2035, net of financing costs     0.0 792.9  
Payments on CLO borrowings     (67.9) (52.0)  
Proceeds from CLO borrowings, net of financing costs     97.9 64.8  
Dividends to common shareholders     (376.6) (379.2)  
Contributions from non-controlling interest holders     269.9 116.9  
Distributions to non-controlling interest holders     (151.7) (83.9)  
Common shares repurchased and net share settlement of equity-based awards     (719.3) (482.8)  
Change in due to/from affiliates financing activities     (208.8) 29.4  
Net cash provided by financing activities     (1,156.5) 6.1  
Effect of foreign exchange rate changes     (8.6) 39.1  
Increase (decrease) in cash, cash equivalents and restricted cash     (389.3) 959.9  
Cash, cash equivalents and restricted cash, beginning of period     1,973.6 1,266.5  
Cash, cash equivalents and restricted cash, end of period $ 1,584.3 2,226.4 1,584.3 2,226.4  
Reconciliation of cash, cash equivalents and restricted cash, end of period:          
Cash and cash equivalents 1,583.5 2,221.7 1,583.5 2,221.7  
Restricted cash 0.8 4.7 0.8 4.7  
Total cash, cash equivalents and restricted cash, end of period 1,584.3 2,226.4 1,584.3 2,226.4 $ 1,973.6
Cash and cash equivalents held at Consolidated Funds $ 1,021.5 $ 1,037.3 $ 1,021.5 $ 1,037.3